Guanhao Biotech Co.,Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • 300238
  • 1d-1.59%
  • 1w-0.90%
  • 1m-7.57%
  • 1y-25.19%
ATH
  • ATH Price$58.94
  • ATH Date2015-06-12
  • % since ATH-83.22%
  • % to ATH495.92%
ATL
  • ATL Price$6.44
  • ATL Date2012-12-03
  • % from ATL53.55%
  • Last Low Price$7.81
  • Last Low Date2024-02-07
  • % From Last Low26.63%
IPO
  • IPO Price$33.00
  • % Current ROI USD-70.03%
  • ATH Price$58.94
  • % ROI ATH 91,506.51%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="300238"]

Key Data [addtoany]

Current price $9.89
Sector Healthcare
Industry Biotechnology
Today's High/Low $10.16/$9.86
Volume 3,483,800.00
Previous Close $10.05
52 Week High/Low $23.38/$7.48
Market Cap 2,622,392,832.00
P/E Ratio 82.4167
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0.31
Annualized Dividend $0
$9.89
[addtoany]

Guanhao Biotech Co.,Ltd. develops, manufactures, and markets regenerative medicine in China. It offers NormalGEN, a type of biological dura repair patch manufactured from animal tissue; GrandNeuro, an artificial dura patch for dura repairing; ThormalGEN, a biological surgical patch manufactured from animal tissue for surgical repairs; DermalGEN, a wound dressing product manufactured from animal tissue for use on burns, scalds, and wounds due to skin loss or trauma; and IREAL breast patch.
The company was founded in 1999 and is based in Guangzhou, China.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity